## NOC: Northrop Grumman Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 0.4% below STRENGTH zone (3.0-6.0%); PEG 3.62 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($560.68)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Northrop awarded Veyron chip R&D deal**
- Source: Defence Blog | 20251224T121000 | Bullish | Relevance: 100%
- Northrop Grumman has been awarded a $59.98 million contract by the Air Force Research Laboratory for the VEYRON effort, which focuses on developing a secure digital beamforming ASIC. This project aims to integrate on-chip Root of Security features to mitigate supply chain risks in advanced military systems such as radar and electronic warfare. The work will be performed at Northrop Grumman's Linthicum Heights facility and is expected to conclude by June 30, 2028.

**2. Northrop Grumman secures $149 million in defense contracts**
- Source: Investing.com | 20251223T223352 | Bullish | Relevance: 100%
- Northrop Grumman has been awarded three defense contracts totaling approximately $149 million for various military technology and systems development projects. These contracts involve research and development for digital beamforming transceivers, maintenance for Air and Missile Defense Workstation Block VII, and manufacturing B-2 forward duct assemblies. The work is distributed across facilities in Maryland, Virginia, and Oklahoma, with completion dates ranging from 2028 to 2031, managed by various U.S. defense agencies.

**3. Northrop Grumman receives $50 million contract modification for LITENING**
- Source: Investing.com | 20251222T224034 | Bullish | Relevance: 100%
- Northrop Grumman Systems Corp. secured a $50 million contract modification for the LITENING CATP program, bringing the total contract value to $1.36 billion. The work will be performed at the companyâ€™s Rolling Meadows, Illinois facility, with completion expected by December 31, 2025, though delivery orders may extend to 2029. The modification, identified as P00033 to previously awarded contract FA8540-19-D-0001, does not obligate immediate funding and excludes Foreign Military Sales.

**4. Northrop Grumman awarded $264.87M Defense Logistics Agency contract modification**
- Source: MSN | 20251222T040854 | Bullish | Relevance: 100%
- Northrop Grumman has been awarded a $264.87 million contract modification by the Defense Logistics Agency. This modification is related to the previous contract for parts and materials for the B-2 platform. The contract will run through September 30, 2029.

**5. Analysts See a 19% Upside to Northrop Grumman Corporation (NOC)**
- Source: Insider Monkey | 20251223T220120 | Somewhat-Bullish | Relevance: 97%
- Analysts have a consensus Strong Buy rating on Northrop Grumman Corporation (NOC) with a one-year average share price target of $685.31, indicating a 19% upside. This follows recent adjustments by Morgan Stanley, Alembic Global, and Citigroup, with continued bullish sentiment on the aerospace and defense sector. Northrop Grumman is a major defense contractor involved in advanced systems.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Alembic Global | $662 | $0 | 0% |
| 2025-12-12 | Citigroup | $654 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Alembic Global | up | Overweight |
| 2025-12-12 | Citigroup | init | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 3 ($0.08M) |
| Sells | 2 ($0.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.5% (+0.8%)
- State Street Corpora: 9.3% (-1.6%)
- Capital Internationa: 8.2% (-1.7%)
- Blackrock Inc.: 6.9% (+1.0%)
- JPMORGAN CHASE & CO: 3.9% (+91.5%)

### Key Risks

1. Valuation stretched: PEG 3.6x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.62 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 26%). Balance sheet: $1.3B free cash flow. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $83.4B |
| Beta | 0.05 |
| 52W Range | $426.24 - $640.90 |
| Short Interest | 1.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.62 |
| Forward P/E | 20.2 |
| Current P/E | 22.4 |
| YoY Growth | 10.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 weakening modestly (-0.7% over 5 days). Below STRENGTH zone by 2.6pp (needs >3.0% for momentum thesis). MRS_5 at 0.3% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (3.55), confirming momentum. RSI neutral at 59. OFD pattern: -DUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.39% (CS: 80) | Neutral |
| RSI_14 | 59.2 | Neutral |
| MACD Histogram | 3.55 | Bullish |
| vs SMA20 | 1.034x | Above |
| vs SMA50 | 1.017x | Above |
| vs SMA200 | 1.073x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $582.40
- **Stop Loss:** $560.68 (3.7% risk)
- **Target:** $604.12 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 41
- **Position Value:** $23,878.40
- **Portfolio %:** 23.88%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite supported by year-end positioning. VIX at cycle lows (13.47) and multiple sectors hitting 52-week highs indicate constructive sentiment, though breadth at 57.9% suggests selectivity remains important. Fed pause expectations and stable macro backdrop support risk assets.*

### Earnings

**Next:** 2026-01-29 (Est: $6.95)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.46 | $7.67 | +18.8% |
| 2025Q2 | $6.80 | $8.15 | +19.9% |
| 2025Q1 | $6.26 | $3.32 | -47.0% |
| 2024Q4 | $6.35 | $6.39 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*